Nilutamide (ANI Pharmaceuticals, Inc.)


Welcome to the PulseAid listing for the Nilutamide drug offered from ANI Pharmaceuticals, Inc.. This Androgen Receptor Antagonists [MoA],Androgen Receptor Inhibitor [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: ANI Pharmaceuticals, Inc.
NON-PROPRIETARY NAME: Nilutamide
SUBSTANCE NAME: NILUTAMIDE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Androgen Receptor Antagonists [MoA],Androgen Receptor Inhibitor [EPC]
ROUTE: ORAL
DOSAGE FORM: TABLET
MARKETING CATEGORY NAME: ANDA
START MARKETING DATE: 2016-07-18
END MARKETING DATE: 0000-00-00


Nilutamide HUMAN PRESCRIPTION DRUG Details:

Item DescriptionNilutamide from ANI Pharmaceuticals, Inc.
LABELER NAME: ANI Pharmaceuticals, Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 150(mg/1)
START MARKETING DATE: 2016-07-18
END MARKETING DATE: 0000-00-00
PRODUCT ID: 62559-173_8d6d69d9-891a-4587-8c70-a74f46232c56
PRODUCT NDC: 62559-173
APPLICATION NUMBER: ANDA207631

Other NILUTAMIDE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
ANI Pharmaceuticals, Inc.Nilutamide
Concordia Pharmaceuticals Inc.Nilandron
sanofi-aventis U.S. LLCNilandron